¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"eosinophil series"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® upper GI series ÇÑ±Û »óºÎÀ§Àå°üÁ¶¿µ¼ú
¼³¸í   
  X-¼± »çÁø¿¡¼­ Àß ³ªÅ¸³ª´Â Á¶¿µÁ¦(¹æ»ç¼±ÃÔ¿µ»ó¿¡¼­ ÇϾé°Ô ³ªÅ¸³ª ÁÖÀ§Á¶Á÷°ú °¨º°ÀÌ ¿ëÀÌÇÏ´Ù)¸¦ ¼·ÃëÇÑ ÈÄ ½Äµµ, À§, »ùâÀÚ, ÀÛÀºÃ¢ÀÚ»óºÎ±îÁö X-¼± ÃÔ¿µÇϹǷνá, ±×°÷ ¼ÒÈ­°ü³»ÀÇ ÀÌ»óº´ÅÍ¿©ºÎ¸¦ °Ë»çÇϴ °Í. Á¶¿µÁ¦´Â ÁַΠ¹Ù·ýÀ» »ç¿ëÇϸ破õ ¼±¸íÇÑ ¿µ»óÀ» ¾ò±âÀ§ÇØ ¹ßÆ÷Á¦¸¦ ÇÔ²² ¼·ÃëÇÏ¿© ¹Ù·ý°ú °ø±âÀÇ ÀÌÁßÁ¶¿µÃÔ¿µÀ» Çϱ⵵ ÇÑ´Ù. ½Äµµ¾Ï, À§¾Ï ¹× ¼ÒÈ­¼º±Ë¾ç°ú ±×¹Û¿¡ ´Ù¾çÇÑ º´º¯ÀÇ Áø´Ü¿¡ È¿°úÀûÀ¸·Î »ç¿ëµÈ´Ù.
¿µ¹® small bowel series ÇÑ±Û ÀÛÀºÃ¢ÀÚ Á¶¿µ¼ú, ¼ÒÀå Á¶¿µ¼ú
¼³¸í   
  ¹æ»ç¼± Á¶¿µÁ¦(¹æ»ç¼±°Ë»ç¿¡¼­ ´Ù¸¥ ºÎÀ§¿Í ´ëÁ¶µÇ´Â ¾ÆÁÖ Èò»öÀ» ¶ì´Â ¹°Áú)ÀΠ¹Ù·ýÀ» ¼·ÃëÇÑ µÚ, ÃÔ¿µÇϴ ÀÛÀºÃ¢ÀÚÀÇ ±âº»ÀûÀΠ¹æ»ç¼± °Ë»ç·Î¼­, ¹æ¹ýÀº 200~300mLÀÇ ¹Ù·ýÀ» ¸ÔÀºµÚ ¹Ù·ýÀÌ ÀÛÀº Ã¢ÀÚ¸¦ Åë°úÇϴ µ¿¾È Á¤±ÔÀû °£°ÝÀ¸·Î ¹æ»ç¼± »çÁøÀ» ÂïÀ½. ÀϹÝÀûÀ¸·Î 2~3½Ã°£ÀÌ °É¸².
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • eosinophil
    È£»ê±¸
  • eosinophil adenoma
    È£»ê»ùÁ¾
  • eosinophil granule
    È£»ê°ú¸³
  • eosinophil leukocyte
    È£»ê¹éÇ÷±¸, È£»ê±¸
  • eosinophil stimulation promotor
    È£»ê±¸ÀÚ±ØÃËÁøÁ¦
  • aromatic series
    ¹æÇâÁ·°è¿­
  • aliphatic series
    Áö¹æÁ·°è¿­
  • discrete series
    ºÒ¿¬¼Ó¼ö¿­
  • exponential series
    Áö¼ö±Þ¼ö
  • granulocytic series
    °ú¸³±¸°è¿­
  • homologous series
    µ¿Á·°è¿­
  • ionization series
    ÀÌ¿ÂÈ­°è¿­
  • lymphocyte series
    ¸²ÇÁ±¸°è¿­
  • series
    1. °è¿­ 2. ±Þ¼ö 3. Á÷·Ä
  • series elastic component
    Á÷¿­Åº·Â¼ººÐ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • eosinophil
    È£»ê±¸
  • series
    °è¿­, ±Þ¼ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • eosinophil adenoma
    È£»ê»ùÁ¾
  • eosinophil
    È£»ê±¸
  • eosinophil granule
    È£»ê¼º°ú¸³
  • eosinophil leukocyte
    È£»ê¼º¹éÇ÷±¸
  • eosinophil chemotactic factor
    È£»ê±¸È­ÇÐÁÖ¼ºÀÎÀÚ, È£»ê±¸È­Çнò¸²ÀÎÀÚ
  • eosinophil stimulation promotor
    È£»ê±¸ÀÚ±ØÃËÁøÁ¦
  • aliphatic series
    Áö¹æ°è¿­
  • aromatic series
    ¹æÇâÁ·°è¿­
  • commutator series
    ±³È¯ÀÚ¿­
  • series elastic component
    Á÷¿­Åº·Â¼ººÐ
  • discrete series
    ºÒ¿¬¼Ó¼ö¿­
  • exponential series
    Áö¼ö±Þ¼ö
  • granulocytic series
    °ú¸³±¸°è¿­
  • homologous series
    µ¿Á·°è¿­
  • hypergeometric series
    ÃʱâÇϱ޼ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Hofmeister s series =lyotropic s.
    È£ÇÁ¸¶À̽ºÅͰ迭(¡­Í§æê).
  • aliphatic series
    Áö¹æ°è¿­.
  • arithmetic series
    µîÂ÷±Þ¼ö.
  • aromatic series
    ¹æÇâÁ·¿­(¡­ðéæê).
  • gallbladder series
    ´ã³¶Á¶¿µ°Ë»ç.
  • gallbladder series
    ´ã³²Á¶¿µ°Ë»ç
  • homologous series
    µ¿Á·°è¿­(¡­Í§æê).
  • hypergeometric series
    ÃʱâÇϱ޼ö(̧˻̰˻Ëà).
  • principal series
    ÁÖ°è¿­(̡˭Ëç).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gastrointestinal series =GI series
    ¹æ»ç À§Àå°üÁ¶¿µ¼ú.
  • eosinophil
    È£»ê±¸
  • eosinophil
    È£»ê±¸(û¿ß«Ï¹)
  • eosinophil
    È£»ê±¸(û¿ß«Ï¹)
  • eosinophil =eosinophile
    È£»ê±¸¼º(û¿ß«Ï¹àõ)ÀÇ, È£»ê±¸(û¿ß«Ï¹), È£»ê¼º ÀÇ
  • eosinophil =eosinophile
    È£»ê±¸¼º(Ì´Ë×Ë´ËÛ)ÀÇ, È£»ê±¸(Ì´Ë×Ë´), È£»ê¼º ÀÇ.
  • eosinophil adenoma
    È£»ê¼º ¼±Á¾.
  • eosinophil cationic protein
    È£»ê±¸¾çÀ̿´ܹé
  • eosinophil chemotactic factor
    È£»ê±¸ È­ÇÐÁÖ¼ºÀÎÀÚ
  • eosinophil chemotactic factor =ECF
    È£»ê±¸ È­ÇÐÁÖ¼ºÀÎÀÚ.
  • eosinophil granule
    È£»ê±¸¼º °ú¸³(¡­Î¨í£).
  • eosinophil leukocyte
    »êÈ£¼º ¹éÇ÷±¸(¡­ÛÜúìϹ).ÀÇÈ£»ê¼º ¹éÇ÷±¸.
  • eosinophil leukocyte
    »êÈ£¼º ¹éÇ÷±¸(?ËÑÌ´Ë´).[ÀÇ]È£»ê¼º ¹éÇ÷±¸.
  • eosinophil production
    È£»ê±¸»ý¼º
  • eosinophil protein X
    È£»ê±¸´Ü¹é X
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chaotropic series
    ¹«Áú¼­(Ùíòñßí) ¾¾¸®½º
  • decay series
    "ºØ±« °è¿­(ÝÚÎÕ֪ͧ), (µ¿) radioactive series"
  • eluotropic series
    ¿ë¸® ¼­¿­ (éÁ×îßíÖª)
  • globo-series glycosphingolipids
    ±Û·Îº¸°è¿­(֪ͧ) ´ç(ÓØ)½ºÇΰíÁöÁú(ò·òõ)
  • Hofmeister series
    È£ÇÁ¸¶À̽ºÅÍ °è¿­(֪ͧ)
  • homologous series
    µ¿Á· °è¿­(ÔÒðé֪ͧ)
  • lacto-series glycosphingolipid
    ¶ôÅä°è¿­(֪ͧ) ±Û¶óÀÌÄÚ½ºÇΰíÁöÁú(ò·òõ)
  • lyotropic series
    À̾װ迭(ìÆäû֪ͧ)
  • radioactive series
    ¹æ»ç¼º °è¿­(Û¯ÞÒàõ֪ͧ)
  • Trappe's eluotropic series
    Æ®¶óÆä ¿ë¸®¼­¿­(éÁ×îßíÖª)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • eosinophil
    È£»ê±¸¼ºÀÇ, È£»ê±¸, È£»ê¼ºÀÇ
  • gallbladder series
    ´ã³¶Á¶¿µ°Ë»ç
  • gastrointestinal series
    À§Àå°üÁ¶¿µ¼ú
  • small bowel series
    ¼ÒÀåÁ¶¿µ¼ú
  • upper gastrointestinal series
    »óºÎÀ§Àå°üÁ¶¿µ¼ú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PIE   1) Post-Infectious Encephalomyelitis
  2) Pulmonary Interstitial Emphysema;...
UGIS Upper Gastro-Intestinal Series
CFU-EOS, CFUEOS colony-forming unit, eosinophil
ECP ectrodactyly-cleft palate [syndrome]; effector cell precursor; endocardial potential; eosinophil cat...
EDF eosinophil differentiation factor; erythroid differentiation factor; extradural fluid
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SEC Series elastic component
EO Eosinophil
ECP Eosinophil Cationic Protein
ECA Eosinophil chemotactic activity
ECF Eosinophil chemotactic factor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • eosinophil adenoma
    È£»ê¼º ¼±Á¾
  • eosinophil chemotactic factor
    È£»ê±¸ È­ÇÐ ÁÖ¼º ÀÎÀÚ
  • eosinophil granule
    È£»ê±¸¼º °ú¸³
  • eosinophil metamyelocyte
    »êÈ£¼º ÈÄ °ñ¼ö ¼¼Æ÷
  • eosinophil protein X
    È£»ê±¸ ´Ü¹é X
  • eosinophil-derived neurotoxin
    È£»ê±¸ À¯·¡ ½Å°æ µ¶¼Ò
  • aromatic series
    ¹æÇâÁ· ¿­
  • Balmer's series
    ¹ß¸Ó °è¿­
  • case-series evaluation
    »ç·Ê Æò°¡
  • electrochemical series
    Àü±â È­ÇÐ ¼­¿­
  • homologous series
    µ¿Á· °è¿­
  • series Á·, ¾Æ°­ÀÇ ÇÏÀ§ÀÌ°í ¸ñÀÇ »óÀ§ÀÎ ºÐ·ùÇÐÀû ¹üÁÖ.

    seriflux

    ¼ö¾ç ¹è¼³¾×, Àå¾× ¹æÃâ, ¿¯Àº ¼ö¾ç¾× ¹æÃâ
  • small bowel series
    ¼ÒÀå Á¶¿µ¼ú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
absolute eosinophil count <haematology, investigation> A measurement (cells per microlitre) of the number of eosinophils in a blood specimen.
This measurement is useful in the evaluation of autoimmune disease, allergies, eczema, leukaemia, asthma and hay fever. Normal absolute eosinophil counts are less than 350 cells/mcl (microlitre).
(27 Sep 1997)
chemotactic factors, eosinophil Cytotaxins liberated from normal or invading cells that specifically attract eosinophils; they may be complement fragments, lymphokines, neutrophil products, histamine or other; the best known is the tetrapeptide ecf-a, released mainly by mast cells.
(12 Dec 1998)
eosinophil Polymorphonuclear leucocyte (granulocyte) of the myeloid series, of which the granules stain red with eosin. Phagocytic, particularly associated with helminth infections and with hypersensitivity.
(18 Nov 1997)
eosinophil adenoma <endocrinology, oncology, tumour> A benign tumour, usually found in the anterior lobe of the pituitary gland, whose cells stain with acid dyes.
Such pituitary tumours may give rise to excessive secretion of growth hormone, resulting in gigantism or acromegaly. A specific type of acidophil adenoma may give rise to nonpuerperal galactorrhoea.
(25 Jun 1999)
eosinophil cationic protein <protein> Arginine rich protein (21 kD) in granules of eosinophils, that damages schistosomula in vitro. Not the same as the MBP (major basic protein) of the granules.
(18 Nov 1997)
eosinophil chemotactic factor of anaphylaxis A peptide (MW 500 to 600) that is chemotactic for eosinophilic leukocytes and is released from disrupted mast cells.
(05 Mar 2000)
eosinophil chemotactic peptide <protein> Tetrapeptides (of which two are identified: VGSE and AGSE) released by mast cells and that are said to both attract and activate eosinophils.
(18 Nov 1997)
eosinophil count A measurement (cells per microlitre) of the number of eosinophils in a blood specimen. This measurement, also called the absolute eosinophil count, is useful in the evaluation of autoimmune disease, allergies, eczema, leukaemia, asthma and hay fever. Normal absolute eosinophil counts are less than 350 cells/mcl (microlitre).
(27 Sep 1997)
eosinophil granule A granule that stains with eosin.
(05 Mar 2000)
eosinophil peroxidase <enzyme> Peroxidase from eosinophil granules distinct from myeloperoxidase; claimed to enhance destruction of fungi, bacteria, schistosomula, toxoplasma, trypanosoma, mast cells, tumour cells in presence of exogenous h2o2 and halide
Registry number: EC 1.11.1.-
(26 Jun 1999)
aromatic series All the compounds derived from benzene, or similar cyclic compounds that obey Huckel's rule, distinguished from those compounds that are acyclic or that contain rings that lack the conjugated double bond structure characteristic of benzene.
(05 Mar 2000)
granulocytic series <haematology> The cells in the several stages of development in the bone marrow leading to the mature granulocyte of the circulation, e.g., myeloblasts, different stages of the myelocyte, granulocytes.
(05 Mar 2000)
myeloid series The granulocytic and the erythrocytic series.
(05 Mar 2000)
Hofmeister series <chemistry> The series of cations Magnesium, Calcium, Sr2+, Ba2+, Li+, Na+, K+, Rb+, Cs+, and of anions citrate3-, tartrate2-, SO42-, acetate-, NO3-, CIO3-, I-, CNS- (among others).
Each series is arranged in order of decreasing ability to: 1) precipitate the dispersed substance of lyophilic soltions; 2) "salt out" organic substances (e.g., aniline, ethyl acetate) from aqueous solutions; or 3) inhibit the swelling of gels.
These effects, among other related ones, are ascribable to the abstraction and binding of water by these ions (i.e., hydration), which also decreases in the orders given, so that (in the monovalent cation series) Li+, with the smallest crystal radius, has the largest hydrated radius, and vice versa for Cs+.
Synonym: lyotropic series.
(05 Mar 2000)
homologous series A series of organic compounds, the succeeding members of which differ from each other by the radical CH2 (as in the fatty series).
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • a series fo
    ÀÏ·ÃÀÇ
  • series
    ¿¬¼ÓµÈ °Í
  • actinide series
    ¾ÇƼ´Ïµå °è¿­;¹æ»ç¼±¿ø¼Ò
  • arithmetic series
    µîÂ÷±Þ¼ö
  • geometric series
    ±âÇÏ(µîºñ)±Þ¼ö
  • harmonic series
    Á¶È­ ±Þ¼ö
  • methane series
    ¸Þź ¿­
  • paraffin series
    ÆÄ¶óÇÉÁ·;¸Þź°è
  • power series
    ¸è±Þ¼ö
  • radioactive series
    ¹æ»ç¼º °è¿­;±«º¯ °è¿­
  • series
    ÀÏ·Ã;¿¬¼Ó;½Ã¸®Áî;¼ö¿­;±Þ¼ö;¿­;Åë;Á÷·Ä;(12À½ À½¾ÇÀÇ)À½·Ä;arithmetical ~ µîÂ÷ ±Þ¼ö
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á